Abstract:Background: Food allergy prevalence has continued to rise over the past decade. While studies have reported threshold doses for multiple foods, large-scale multi-food allergen studies are lacking. Our goal was to identify threshold dose distributions and predictors of severe reactions during blinded oral food challenges (OFCs) in multi-food allergic patients. Methods: A retrospective chart review was performed on all Stanford-initiated clinical protocols involving standardized screening OFCs to any of 11 food allergens at 7 sites. Interval-censoring survival analysis was used to calculate eliciting dose (ED) curves for each food. Changes in severity and ED were also analyzed among participants who had repeated challenges to the same food. Results: Of 428 participants, 410 (96%) had at least one positive challenge (1445 standardized OFCs with 1054 total positive challenges). Participants undergoing peanut challenges had the highest ED50 (29.9 mg), while those challenged with egg or pistachio had the lowest (7.07 or 1.7 mg, respectively). The most common adverse event was skin related (54%), followed by gastrointestinal (GI) events (33%). A history of asthma was associated with a significantly higher risk of a severe reaction (hazard ratio [HR]: 2.37, 95% confidence interval [CI]: 1.36, 4.13). Higher values of allergen-specific IgE (sIgE) and sIgE to total IgE ratio (sIgEr) were also associated with higher risk of a severe reaction (1.49 [1.19, 1.85] and 1.84 [1.30, 2.59], respectively). Participants undergoing cashew, peanut, pecan, sesame, and walnut challenges had more severe reactions as ED increased. In participants who underwent repeat challenges, the ED did not change (p = 0.66), but reactions were more severe (p = 0.02). Conclusions: Participants with a history of asthma, high sIgEr, and/or high values of sIgE were found to be at higher risk for severe reactions during food challenges. These findings may help to optimize food challenge dosing schemes in multi-food allergic, atopic patients, specifically at lower doses where the majority of reactions occur. Trials Registration Number: ClinicalTrials. gov number NCT03539692; https://clinicaltrials.gov/ct2/show/NCT03539692.

Joint transcriptomic and cytometric study of peanut allergic children reveals molecular and cellular cross-talk in reaction thresholds

Predicting reactivity threshold in children with anaphylaxis to peanut

Traffic of eosinophil-lineage committed progenitors to the lung tissue of sensitised mice following allergen challenge

Can we predict severe reactions during peanut challenges in children?

Airway exposure initiates peanut allergy by involving the IL-1 pathway and T follicular helper cells in mice

Analysis of Differentially expressed genes and Molecular pathways in Peanut Allergy Induced Dynamic Changes involved in Peanut-Specific Immune Responses: A Systematic and Bioinformatics Approach

A positive feedback loop reinforces the allergic immune response in human peanut allergy

Peanut allergen characterization and allergenicity throughout development

Peanut allergen induces more serious allergic reactions than other allergens involving MAPK signaling pathways

Fecal IgE Analyses Reveal a Role for Stratifying Peanut-Allergic Patients

Utility of food allergy thresholds

Genome-Wide Association Study Identifies Peanut Allergy-Specific Loci and Evidence of Epigenetic Mediation in Us Children

Diagnosing peanut allergy with skin prick and specific IgE testing

Peanut-specific IgG subclasses as biomarkers of peanut allergy in LEAP study participants

Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges

A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 mice

Clinical utility analysis of the Hoxb8 mast cell activation test for the diagnosis of peanut allergy

Group 2 Innate Lymphoid Cells Promote Development of T Follicular Helper Cells and Initiate Allergic Sensitization to Peanuts

Is Component-Specific Antibody Testing Sufficient to Replace the Oral Food Challenge in the Diagnostics of Peanut-Sensitized Children? A Proof-of-Concept Study

Serologic Measurements for Peanut Allergy: Predicting Clinical Severity is Complex

Different airborne particulates trigger distinct immune pathways leading to peanut allergy in a mouse model